U.S. markets closed
  • S&P 500

    3,825.33
    +39.95 (+1.06%)
     
  • Dow 30

    31,097.26
    +321.83 (+1.05%)
     
  • Nasdaq

    11,127.84
    +99.11 (+0.90%)
     
  • Russell 2000

    1,727.76
    +19.77 (+1.16%)
     
  • Crude Oil

    108.46
    +2.70 (+2.55%)
     
  • Gold

    1,812.90
    +5.60 (+0.31%)
     
  • Silver

    19.77
    -0.51 (-2.50%)
     
  • EUR/USD

    1.0426
    -0.0057 (-0.54%)
     
  • 10-Yr Bond

    2.8890
    -0.0830 (-2.79%)
     
  • GBP/USD

    1.2103
    -0.0072 (-0.59%)
     
  • USD/JPY

    135.1750
    -0.5530 (-0.41%)
     
  • BTC-USD

    19,278.96
    +148.04 (+0.77%)
     
  • CMC Crypto 200

    420.84
    +0.70 (+0.17%)
     
  • FTSE 100

    7,168.65
    -0.63 (-0.01%)
     
  • Nikkei 225

    25,935.62
    -457.42 (-1.73%)
     

Top 10 Stock Picks of John Overdeck and David Siegel’s Two Sigma Advisors

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·11 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

In this article, we discuss the top 10 stock picks of John Overdeck and David Siegel's Two Sigma Advisors. If you want to skip our detailed analysis of these stocks, go directly to the Top 5 Stock Picks of John Overdeck and David Siegel's Two Sigma Advisors.

Two Sigma Advisors was co-founded by John Overdeck and David Siegel in 2001. The New York-based hedge fund has a portfolio valued at $38.5 billion, with discretionary assets under management of $76 billion as per the 13F filings from Q3 2021. The investment portfolio at Two Sigma Advisors is concentrated in the healthcare, finance, information technology, consumer discretionary, and communications sectors.

John Overdeck completed his Bachelor’s in Mathematics and earned a Master’s in Statistics from Stanford University, and started his career at D.E. Shaw & Co, where he rose through the ranks to eventually become the managing director. He also spent two years working at Amazon.com, Inc. (NASDAQ:AMZN), as vice president and technical assistant to Jeff Bezos. In his time at the company, Overdeck was also incharge of the customer relationship management and customer technology at Amazon.com, Inc. (NASDAQ:AMZN). He left Amazon.com, Inc. (NASDAQ:AMZN) to start his own hedge fund in 2001.

On the other hand, David Siegel is a computer scientist, having graduated from Princeton and holding a PhD in computer science from Massachusetts Institute of Technology, where he specialized in artificial intelligence. At Two Sigma, he uses AI and multiple algorithms to uncover the value in big data, which directs him to make strategic and data-driven decisions regarding investments. Both co-founders are actively involved in multiple philanthropic endeavors.

Top 10 Stock Picks of John Overdeck and David Siegel's Two Sigma Advisors
Top 10 Stock Picks of John Overdeck and David Siegel's Two Sigma Advisors

David Siegel of Two Sigma Advisors

The most notable stocks from Two Sigma Advisors’ Q3 portfolio include Meta Platforms, Inc. (NASDAQ:FB), Apple Inc. (NASDAQ:AAPL), Alphabet Inc. (NASDAQ:GOOG), and Microsoft Corporation (NASDAQ:MSFT), among others discussed in detail below.

Our Methodology

We used the investment portfolio of John Overdeck and David Siegel's Two Sigma Advisors to create a list of the firm’s top 10 stock picks as of Q3 2021.

Top Stocks Picks of John Overdeck and David Siegel's Two Sigma Advisors

10. Charter Communications, Inc. (NASDAQ:CHTR)

Two Sigma Advisors’ Stake Value: $402,286,000

Percentage of Two Sigma Advisors’ 13F Portfolio: 1.04%

Number of Hedge Fund Holders: 74

Charter Communications, Inc. (NASDAQ:CHTR), a Connecticut-based telecommunications and media company, offers multiple products and services under its brand, Spectrum, including broadband, cable television, digital telephone, HDTV, internet security, and VoIP phone. Two Sigma Advisors holds a $402.2 million stake in Charter Communications, Inc. (NASDAQ:CHTR), which accounts for 1.04% of the firm’s total Q3 securities.

Chris Hohn’s TCI Fund Management is the leading Charter Communications, Inc. (NASDAQ:CHTR) stakeholder, with 10.35 million shares valued at $7.53 billion. As per Insider Monkey’s records, 74 hedge funds reported owning stakes in Charter Communications, Inc. (NASDAQ:CHTR) at the end of Q3, worth $18.79 billion.

Charter Communications, Inc. (NASDAQ:CHTR) posted Q3 results on October 29. EPS in the period totaled $6.50, beating estimates by $0.71. The $13.15 billion revenue also outperformed estimated revenue by almost $200 million.

After strong Q3 results but weak subscribers, the company’s performance was deemed mixed by Loop Capital analyst Alan Gould, who lowered the price target on Charter Communications, Inc. (NASDAQ:CHTR) to $730 from $815 on November 22, and kept a Hold rating on the shares.

In addition to Meta Platforms, Inc. (NASDAQ:FB), Apple Inc. (NASDAQ:AAPL), Alphabet Inc. (NASDAQ:GOOG), and Microsoft Corporation (NASDAQ:MSFT), Charter Communications, Inc. (NASDAQ:CHTR) is a notable stock from Two Sigma Advisors’ Q3 portfolio.

Here is what ClearBridge Investments has to say about Charter Communications, Inc. (NASDAQ:CHTR) in its Q1 2021 investor letter:

“The portfolio’s quality bias and valuation discipline have generated compelling returns over time with typically strong relative results in more challenging environments as it did through the first three quarters of 2020. However, that same quality bias tends to create a more challenging relative performance environment for the Strategy during periods of sharp economic acceleration, which tend to benefit stocks that are more commodity linked or of lower quality. This has been the case during the vaccine- and stimulus-driven rally experienced late last year and during the most recent quarter. Sectors that lagged in the quarter included communication services, where Charter trailed after generating robust returns earlier in the recovery.”

9. Meta Platforms, Inc. (NASDAQ:FB)

Two Sigma Advisors’ Stake Value: $403,771,000

Percentage of Two Sigma Advisors’ 13F Portfolio: 1.04%

Number of Hedge Fund Holders: 248

Mark Zuckerberg’s tech corporation, Meta Platforms, Inc. (NASDAQ:FB), posted its Q3 earnings on October 25. EPS for the quarter was reported as $3.22, exceeding estimates by $0.04.

John Overdeck and David Siegel's Two Sigma Advisors owns 1.18 million Meta Platforms, Inc. (NASDAQ:FB) shares, worth $403.77 million as of the third quarter, representing 1.04% of the firm’s portfolio. The hedge fund increased its stake in Meta Platforms, Inc. (NASDAQ:FB) by almost 765% as compared to the prior quarter.

The leading Meta Platforms, Inc. (NASDAQ:FB) stakeholder is Ken Fisher’s Fisher Asset Management, holding a $2.5 billion position in the company. A total of 248 funds in the database of hedge funds tracked by Insider Monkey reported owning stakes in Meta Platforms, Inc. (NASDAQ:FB) as of Q3 2021, worth over $38.5 billion. This is compared to 266 funds being bullish on the tech giant in the preceding quarter, with total stakes amounting to $42.3 billion.

Here is what Jefferies Group has to say about Meta Platforms, Inc. (NASDAQ:FB) in its Q3 2021 investor letter:

“While still early, FB is in the process of building the platforms that will ultimately support the development of the Metaverse. We look at FB’s position through the lens of 4 current investment initiatives: 1) Oculus VR hardware, 2) Smart glasses, 3) Augmented Reality lenses, and 4) “Horizon Workrooms” Oculus Virtual Reality hardware: Since acquiring Oculus in 2014 ($2B deal), FB has been focused on developing best-in-class hardware and complementary software & services to support VR experiences. The Oculus Quest 2 is FB’s newest VR headset; it retails at $299 and allows users to play games, try fitness classes, play sports, and watch concerts in virtual environments. Most importantly, Quest 2 is linked to users’ Facebook accounts, which means users can seamlessly connect with friends in virtual environments to play games or spend time together. We believe one of FB’s biggest differentiators in VR is its large array of non-gaming experiences that were designed for Oculus. For instance, users can explore extreme terrain in National Geographic Explore VR, join virtual fitness classes, or simulate being a chef. As FB’s hardware continues to improve and becomes less cumbersome, we would expect a flywheel of greater developer and user adoption of VR…” (Click here to see the full text)

8. Apple Inc. (NASDAQ:AAPL)

Two Sigma Advisors’ Stake Value: $442,173,000

Percentage of Two Sigma Advisors’ 13F Portfolio: 1.14%

Number of Hedge Fund Holders: 120

Apple Inc. (NASDAQ:AAPL), a multinational tech corporation specializing in consumer electronics and computer software, is one of the top stocks from Two Sigma Advisors’ Q3 portfolio. The hedge fund holds 3.12 million Apple Inc. (NASDAQ:AAPL) shares, worth $442.1 million as of September this year, representing 1.14% of the total 13F securities.

UBS analyst David Vogt, on November 24, kept a Buy rating with a $175 price target on Apple Inc. (NASDAQ:AAPL), stating that demand for the company's products remains strong and supply chain challenges are likely easing up since there are shorter wait times for Apple Inc. (NASDAQ:AAPL) products.

Apple Inc. (NASDAQ:AAPL) posted Q3 earnings on October 28, with EPS for the quarter being $1.24, in line with analysts’ estimates.

Warren Buffett’s Berkshire Hathaway is the leading Apple Inc. (NASDAQ:AAPL) stakeholder, with a $125.5 billion position in the company. Overall, 120 hedge funds were bullish on Apple Inc. (NASDAQ:AAPL) as of Q3 2021, with total stakes amounting to $146 billion as per Insider Monkey’s records.

Here is what ClearBridge Investments has to say about Apple Inc. (NASDAQ:AAPL) in its Q1 2021 investor letter:

“As we actively manage holdings and position sizes, we look to regularly recycle capital into more compelling opportunities. Maintaining our valuation discipline, we sharply reduced our position in Apple, whose shares more than doubled following our initial purchase in mid-2019 with an earnings multiple rising from the low-to-mid teens to nearly 30x.”

7. Intel Corporation (NASDAQ:INTC)

Two Sigma Advisors’ Stake Value: $444,077,000

Percentage of Two Sigma Advisors’ 13F Portfolio: 1.15%

Number of Hedge Fund Holders: 66

Intel Corporation (NASDAQ:INTC) reported on October 21 its Q3 results. EPS for the quarter came in at $1.67, topping estimates by $0.61.

Intel Corporation (NASDAQ:INTC) is a multinational tech corporation engaged in manufacturing semiconductors, integrated graphics, microprocessors, and consumer electronics, among other related products.

John Overdeck and David Siegel's Two Sigma Advisors, as of September this year, owns 8.33 million shares in Intel Corporation (NASDAQ:INTC), worth $444 million, representing 1.15% of the firm’s total investments.

Northland analyst Gus Richard upgraded Intel Corporation (NASDAQ:INTC) to Market Perform from Underperform with a $49 price target on November 1.

One of the leading Intel Corporation (NASDAQ:INTC) stakeholders is Seth Klarman’s Baupost Group, with 19.74 million shares valued at $1.05 billion. Of the 867 hedge funds monitored by Insider Monkey as of Q3 2021, 66 funds were long Intel Corporation (NASDAQ:INTC), down from 78 funds in the preceding quarter.

Here is what Alger Spectra Fund has to say about Intel Corporation (NASDAQ:INTC) in their Q1 2021 investor letter:

“Short exposure to Intel also detracted from performance. Intel designs and manufactures semiconductors for the computing and communications industries. Intel’s proprietary intellectual strength and manufacturing prowess versus the competition is deteriorating, which is causing the company to lose market share and profit opportunities. The short position detracted from portfolio returns as the share price reacted positively to the announcement of Pat Gelsinger being hired as chief executive officer, a stronger-than-anticipated quarterly earnings report driven by unusually robust PC sales that we believe are unsustainable and the unveiling of “Intel Unleashed,” a new long-term program to help improve manufacturing and spur innovation. This program involves opening two fabrication plants in Arizona, which confirms Intel’s commitment to continue as an integrated design manufacturer. Importantly, Intel continues to experience issues with its next generation server chips which are disadvantaging Intel versus the competition.”

6. Eli Lilly and Company (NYSE:LLY)

Two Sigma Advisors’ Stake Value: $467,992,000

Percentage of Two Sigma Advisors’ 13F Portfolio: 1.21%

Number of Hedge Fund Holders: 62

Eli Lilly and Company (NYSE:LLY) is an American pharmaceutical company engaged in clinical trials and research for creating unique medicines and treatments for Alzheimer's, cancer, diabetes, immunology, pain management, and COVID-19. Eli Lilly and Company (NYSE:LLY)’s medicines are distributed across 120 countries, with clinical research conducted in more than 55 countries.

John Overdeck and David Siegel, via Two Sigma Advisors, own over 2 million shares in Eli Lilly and Company (NYSE:LLY), worth almost $468 million as of Q3, representing 1.21% of the firm’s stock portfolio. The hedge fund increased its stake dramatically in Eli Lilly and Company (NYSE:LLY) in Q3 by 6720%, when compared to the previous quarter.

At the end of the third quarter of 2021, 62 hedge funds were bullish on Eli Lilly and Company (NYSE:LLY), with Rajiv Jain’s GQG Partners being one of the leading stakeholders, owning a position worth almost $377 million in the company.

Truist analyst Robyn Karnauskas on November 24 raised the price target on Eli Lilly and Company (NYSE:LLY) to $301 from $262 and kept a Buy rating on the shares, as she was positive about the major pharma industry as a whole.

In addition to Meta Platforms, Inc. (NASDAQ:FB), Apple Inc. (NASDAQ:AAPL), Alphabet Inc. (NASDAQ:GOOG), and Microsoft Corporation (NASDAQ:MSFT), Eli Lilly and Company (NYSE:LLY) is a notable stock from Two Sigma Advisors’ Q3 portfolio.

Here is what Baron Funds has to say about Eli Lilly and Company (NYSE:LLY) in its Q2 2021 investor letter:

“We started a position in Eli Lilly and Company, a large-cap pharmaceutical company. We think Lilly has a healthy base business with limited near-term patent expirations, a strong pipeline, and potential for significant margin expansion, which should translate to high single-digit revenue growth and mid-teens earnings growth over the next five years. Lilly’s pipeline includes donanemab, a potential blockbuster drug which the company is developing for Alzheimer’s disease and which recently received Breakthrough Therapy Designation by the FDA.”

Click to continue reading and see Top 5 Stock Picks of John Overdeck and David Siegel's Two Sigma Advisors.

Suggested articles:

Disclosure: None. Top 10 Stock Picks of John Overdeck and David Siegel's Two Sigma Advisors is originally published on Insider Monkey.